Researchers turn powerful, viscous disinfectants into breathable mist for the first time

A team of engineers and physicians in San Diego have developed a device that diffuses potent disinfectants for airborne delivery. Notably, the device works on a range of disinfectants that have never been atomized before, such as Triethylene glycol, or TEG. In a study published in the August issue of Applied Microbiology and Biotechnology, the team used the device to ...

Read More »

Novel PET imaging noninvasively pinpoints colitis inflammation sites

A novel positron emission tomography (PET) imaging method shows promise for noninvasively pinpointing sites of inflammation in people with inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn’s disease. The University of California, Los Angeles (UCLA), study is featured inThe Journal of Nuclear Medicine. The U.S. Centers for Disease Control states that approximately three million Americans reported being diagnosed ...

Read More »

Low- or no-calorie soft drinks linked to improved outcomes in colon cancer

Drinking artificially sweetened beverages is associated with a significantly lower risk of colon cancer recurrence and cancer death, a team of investigators led by a Yale Cancer Center scientist has found. The study was published in PLOS ONE. “Artificially sweetened drinks have a checkered reputation in the public because of purported health risks that have never really been documented,” said the ...

Read More »

Researchers improve screening rates for West Virginia’s second-deadliest cancer

In West Virginia, where colorectal cancer is the second-deadliest type of cancer, half of all colorectal cancers elude diagnosis until they have already grown beyond the colon. With Medicaid expansion, more West Virginians now have health insurance for cancer screening, yet many barriers to screening persist. West Virginia University researchers are working to improve screening rates for the state, which ...

Read More »

New program advances technologies and treatments of gastrointestinal, metabolic ailments

Cedars-Sinai has launched an initiative to accelerate the development of novel drugs, devices and therapies aimed at improving treatments for patients with gastrointestinal and metabolic diseases. Physician-scientists and others in the Medically Associated Science and Technology (MAST) Program are focusing their research expertise on disorders of the microbiome. This naturally occurring ecosystem of single-cell organisms — including bacteria, fungi, viruses ...

Read More »